Files in This Item:


Title: Volume replacement in dengue shock syndrome.
Authors: Wills, Bridget
Issue Date: Dec-2001
Publisher: WHO Regional Office for South-East Asia
Place of publication: New Delhi
Language: English
Abstract: The treatment of dengue shock syndrome (DSS) is a medical emergency. Prompt and vigorous volume replacement therapy is required, with extreme care to avoid fluid overload. Recognition of the importance of increased vascular permeability in the pathophysiology of DSS and of the critical need for parenteral fluids in resuscitation has had a dramatic effect on mortality from the disease over the last 40 years. However, until recently there has been little research to determine the optimal fluid regimen, and the choice of fluid has remained largely empirical. Colloid and crystalloid fluids have different physicochemical properties which influence the patterns of distribution and elimination, as well as the secondary osmotic effects. In two recent double-blind randomized trials in Viet Nam, initial resuscitation with colloid fluids (dextran 70 or 3% gelatin) restored cardiac index and pulse pressure and normalized haematocrit more quickly than either of the crystalloid fluids (physiological saline or Ringer’s lactate). There was no difference, however, in the overall recovery time or the subsequent requirement for fluids. From the larger study it was apparent that the major determinant of clinical response was the width of the pulse pressure at presentation with shock, the small number of children with pulse pressures of
Description: Dengue Bulletin. 2001 Dec; 25: 50-55.
Keywords: Dengue
Dengue Hemorrhagic Fever
Dengue Shock Syndrome
Medical Emergency
ISSN: 0250-8362
Appears in Collections:Dengue Bulletin

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.